Melatonin: The dawning of a treatment for fibrosis?

Journal of Pineal Research

Volumn 60, Issue 2, 2016, Pages 121-131

  Hu, Wei ^a,b   Ma, Zhiqiang ^c   Jiang, Shuai ^a   Fan, Chongxi ^c   Deng, Chao ^d   Yan, Xiaolong ^c   Di, Shouyin ^c   Lv, Jianjun ^a   Reiter, Russel J ^e   Yang, Yang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Beijing Military Area Command ^*  (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

fibrosis; melatonin; protective effects

Indexed keywords

CHEMOKINE; CYTOKINE; MELATONIN;

ARTICLE; EFFECTOR CELL; EXTRACELLULAR MATRIX; FIBROGENESIS; FIBROSIS; HEART; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY FIBROSIS; LIVER; LIVER FIBROSIS; LUNG; LUNG FIBROSIS; NONHUMAN; REGULATORY MECHANISM; ANIMAL; HEART DISEASES; KIDNEY DISEASES; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS;

ANIMALS; EXTRACELLULAR MATRIX; FIBROSIS; HEART DISEASES; HUMANS; KIDNEY DISEASES; LIVER CIRRHOSIS; MELATONIN; PULMONARY FIBROSIS;

EID: 84956916027     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12302     Document Type: Article

References (123)

1. Birbrair A, Zhang T, Wang ZM, et al., Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am J Physiol Cell Physiol 2013; 305: C1098-C1113.
2. Drobnik J, Karbownik-Lewinska M, Szczepanowska A, et al., Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar. J Pineal Res 2008; 45: 285-290.
3. di Lullo GA, Sweeney SM, Korkko J, et al., Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J Biol Chem 2002; 277: 4223-4231.
4. Pugazhenthi K, Kapoor M, Clarkson AN, et al., Melatonin accelerates the process of wound repair in full-thickness incisional wounds. J Pineal Res 2008; 44: 387-396.
5. Rockey DC, Bell PD, Hill JA,. Fibrosis-a common pathway to organ injury and failure. N Engl J Med 2015; 372: 1138-1149.
6. Drobnik J, Slotwinska D, Olczak S, et al., Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar. J Physiol Pharmacol 2011; 62: 29-35.
7. Simko F, Pechanova O, Pelouch V, et al., Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J Hypertens Suppl 2009; 27: S5-S10.
8. Zaitone S, Hassan N, El-Orabi N, et al., Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. Eur J Pharmacol 2011; 662: 70-77.
9. Tahan V, Ozaras R, Canbakan B, et al., Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res 2004; 37: 78-84.
10. Pan L, Fu JH, Xue XD, et al., Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J Pediatr 2009; 5: 216-221.
11. Taslidere E, Esrefoglu M, Elbe H, et al., Protective effects of melatonin and quercetin on experimental lung injury induced by carbon tetrachloride in rats. Exp Lung Res 2014; 40: 59-65.
12. Ozbek E, Ilbey YO, Ozbek M, et al., Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. J Endourol 2009; 23: 1165-1173.
13. Ogeturk M, Kus I, Kavakli A, et al., Reduction of carbon tetrachloride-induced nephropathy by melatonin administration. Cell Biochem Funct 2005; 23: 85-92.
14. Rodella LF, Filippini F, Bonomini F, et al., Beneficial effects of melatonin on nicotine-induced vasculopathy. J Pineal Res 2010; 48: 126-132.
15. Marquez E, Sanchez-Fidalgo S, Calvo JR, et al., Acutely administered melatonin is beneficial while chronic melatonin treatment aggravates the evolution of TNBS-induced colitis. J Pineal Res 2006; 40: 48-55.
16. De Castro-Silva C, de Bruin VM, Cunha GM, et al., Melatonin improves sleep and reduces nitrite in the exhaled breath condensate in cystic fibrosis-a randomized, double-blind placebo-controlled study. J Pineal Res 2010; 48: 65-71.
17. Karimfar MH, Rostami S, Haghani K, et al., Melatonin alleviates bleomycin-induced pulmonary fibrosis in mice. J Biol Regul Homeost Agents 2015; 29: 327-334.
18. Hrenak J, Paulis L, Repova K, et al., Melatonin and renal protection: novel perspectives from animal experiments and human studies (review). Curr Pharm Des 2015; 21: 936-949.
19. Sewerynek E, Melchiorri D, Chen L, et al., Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radic Biol Med 1995; 19: 903-909.
20. Beni SM, Kohen R, Reiter RJ, et al., Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2004; 18: 149-151.
21. Govender J, Loos B, Marais E, et al., Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin. J Pineal Res 2014; 57: 367-380.
22. Yang GH, Li YC, Wang ZQ, et al., Protective effect of melatonin on cigarette smoke-induced restenosis in rat carotid arteries after balloon injury. J Pineal Res 2014; 57: 451-458.
23. Cardinali DP, Golombek DA, Rosenstein RE, et al., Melatonin site and mechanism of action: single or multiple? J Pineal Res 1997; 23: 32-39.
24. Reiter RJ, Tan DX, Manchester LC, et al., Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52: 11-28.
25. Miettunen J, Raevuori A,. A meta-analysis of temperament in axis I psychiatric disorders. Compr Psychiatry 2012; 53: 152-166.
26. Vriend J, Reiter RJ,. Melatonin feedback on clock genes: a theory involving the proteasome. J Pineal Res 2015; 58: 1-11.
27. Cardinali DP, Furio AM, Reyes MP,. Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent. Ann N Y Acad Sci 2005; 1057: 327-336.
28. Borges Lda S, Dermargos A, Da Silva Junior EP, et al., Melatonin decreases muscular oxidative stress and inflammation induced by strenuous exercise and stimulates growth factor synthesis. J Pineal Res 2015; 58: 166-172.
29. Jin H, Wang Y, Zhou L, et al., Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells. J Pineal Res 2014; 57: 442-450.
30. Cano Barquilla P, Pagano ES, Jimenez-Ortega V, et al., Melatonin normalizes clinical and biochemical parameters of mild inflammation in diet-induced metabolic syndrome in rats. J Pineal Res 2014; 57: 280-290.
31. Chen J, Chen G, Li J, et al., Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: a possible role for the regulation of pro-inflammatory cytokines. J Pineal Res 2014; 57: 340-347.
32. Garcia JJ, Lopez-Pingarron L, Almeida-Souza P, et al., Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 2014; 56: 225-237.
33. Manchester LC, Coto-Montes A, Boga JA, et al., Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res 2015; 59: 403-419.
34. Zhang HM, Zhang Y,. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 2014; 57: 131-146.
35. Wang X,. The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther 2009; 15: 345-357.
36. Ben Soussia I, Mies F, Naeije R, et al., Melatonin down-regulates volume-sensitive chloride channels in fibroblasts. Pflugers Arch 2012; 464: 273-285.
37. Martinez-Martinez E, Jurado-Lopez R, Valero-Munoz M, et al., Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J Hypertens 2014; 32: 1104-1114; discussion 1114.
38. Zhang JC, Xie YF, Liu SJ, et al., The expression of melatonin receptor in human hypertrophic scar. Zhonghua Zheng Xing Wai Ke Za Zhi 2010; 26: 203-207 (in Chinese).
39. Aust S, Jager W, Kirschner H, et al., Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1. Wien Med Wochenschr 2008; 158: 575-578.
40. Abdel-Wanis ME, Kawahara N,. The role of neurofibromin and melatonin in pathogenesis of pseudarthrosis after spinal fusion for neurofibromatous scoliosis. Med Hypotheses 2002; 58: 395-398.
41. Sutken E, Aral E, Ozdemir F, et al., Protective role of melatonin and coenzyme Q10 in ochratoxin A toxicity in rat liver and kidney. Int J Toxicol 2007; 26: 81-87.
42. Ogeturk M, Kus I, Pekmez H, et al., Inhibition of carbon tetrachloride-mediated apoptosis and oxidative stress by melatonin in experimental liver fibrosis. Toxicol Ind Health 2008; 24: 201-208.
43. Kus I, Ogeturk M, Oner H, et al., Protective effects of melatonin against carbon tetrachloride-induced hepatotoxicity in rats: a light microscopic and biochemical study. Cell Biochem Funct 2005; 23: 169-174.
44. Tas U, Ogeturk M, Meydan S, et al., Hepatotoxic activity of toluene inhalation and protective role of melatonin. Toxicol Ind Health 2011; 27: 465-473.
45. Gurses I, Ozeren M, Serin M, et al., Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract 2014; 210: 863-871.
46. Sezer A, Hatipoglu AR, Usta U, et al., Effects of intraperitoneal melatonin on caustic sclerosing cholangitis due to scolicidal solution in a rat model. Curr Ther Res Clin Exp 2010; 71: 118-128.
47. Stacchiotti A, Lavazza A, Rezzani R, et al., Cyclosporine A-induced kidney alterations are limited by melatonin in rats: an electron microscope study. Ultrastruct Pathol 2002; 26: 81-87.
48. Tahan V, Atug O, Akin H, et al., Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats. J Pineal Res 2009; 46: 401-407.
49. Hu S, Yin S, Jiang X, et al., Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol 2009; 616: 287-292.
50. Sun CK, Lee FY, Kao YH, et al., Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat. J Pineal Res 2015; 58: 137-150.
51. Esrefoglu M, Gul M, Emre MH, et al., Protective effect of low dose of melatonin against cholestatic oxidative stress after common bile duct ligation in rats. World J Gastroenterol 2005; 11: 1951-1956.
52. Choi HS, Kang JW, Lee SM,. Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. Transl Res 2015; 166: 292-303.
53. Serin M, Gulbas H, Gurses I, et al., The histopathological evaluation of the effectiveness of melatonin as a protectant against acute lung injury induced by radiation therapy in a rat model. Int J Radiat Biol 2007; 83: 187-193.
54. Aktas C, Kanter M, Erboga M, et al., Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats. Toxicol Ind Health 2014; 30: 835-844.
55. Atalik KE, Keles B, Uyar Y, et al., Response to vasoconstrictor agents by detrusor smooth muscles from cisplatin-treated rats and antioxidant treatment. Methods Find Exp Clin Pharmacol 2010; 32: 305-310.
56. Tahan G, Akin H, Aydogan F, et al., Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats. Can J Surg 2010; 53: 313-318.
57. Zhao H, Wu QQ, Cao LF, et al., Melatonin inhibits endoplasmic reticulum stress and epithelial-mesenchymal transition during bleomycin-induced pulmonary fibrosis in mice. PLoS ONE 2014; 9: e97266.
58. Cruz A, Padillo FJ, Torres E, et al., Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J Pineal Res 2005; 39: 143-150.
59. Crespo I, San-Miguel B, Fernandez A, et al., Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice. Transl Res 2015; 165: 346-357.
60. Xie YF, Zhang JC, Liu SJ, et al., Effect of melatonin on proliferation and apoptosis of fibroblasts in human hypertrophic scar. Zhonghua Shao Shang Za Zhi 2011; 27: 422-426 (in Chinese).
61. Lawrance IC, Rogler G, Bamias G, et al., Cellular and molecular mediators of intestinal fibrosis. J Crohns Colitis 2015; pii: j.crohns.2014.09.008. [Epub ahead of print]
62. Sziksz E, Pap D, Lippai R, et al., Fibrosis related inflammatory mediators: role of the IL-10 cytokine family. Mediators Inflamm 2015; 2015: 764641.
63. Didonato JA, Mercurio F, Karin M,. NF-kappaB and the link between inflammation and cancer. Immunol Rev 2012; 246: 379-400.
64. Yamamoto Y, Gaynor RB,. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107: 135-142.
65. Dambacher J, Beigel F, Zitzmann K, et al., The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 2009; 58: 1207-1217.
66. Kim MS, Radinger M, Gilfillan AM,. The multiple roles of phosphoinositide 3-kinase in mast cell biology. Trends Immunol 2008; 29: 493-501.
67. Liu Y, Zhu H, Su Z, et al., IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCbeta/Erk1/2/NF-kappaB-dependent signaling pathway. Int Immunol 2012; 24: 605-612.
68. Guo X, Wang XF,. Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009; 19: 71-88.
69. Martinez-Martinez E, Miana M, Jurado-Lopez R, et al., The potential role of leptin in the vascular remodeling associated with obesity. Int J Obes (Lond) 2014; 38: 1565-1572.
70. Oh CJ, Kim JY, Min AK, et al., Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling. Free Radic Biol Med 2012; 52: 671-682.
71. Oh CJ, Kim JY, Choi YK, et al., Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling. PLoS ONE 2012; 7: e45870.
72. Massague J,. TGFbeta signalling in context. Nat Rev Mol Cell Biol 2012; 13: 616-630.
73. Wang H, Wei W, Wang NP, et al., Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sci 2005; 77: 1902-1915.
74. Czechowska G, Celinski K, Korolczuk A, et al., Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats. J Physiol Pharmacol 2015; 66: 567-579.
75. Yeung HM, Hung MW, Lau CF, et al., Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J Pineal Res 2015; 58: 12-25.
76. Oliveira LG, Kuehn CC, dos Santos CD, et al., Protective actions of melatonin against heart damage during chronic Chagas disease. Acta Trop 2013; 128: 652-658.
77. Kim GD, Lee SE, Kim TH, et al., Melatonin suppresses acrolein-induced IL-8 production in human pulmonary fibroblasts. J Pineal Res 2012; 52: 356-364.
78. Gomez-Florit M, Ramis JM, Monjo M,. Anti-fibrotic and anti-inflammatory properties of melatonin on human gingival fibroblasts in vitro. Biochem Pharmacol 2013; 86: 1784-1790.
79. Erol FS, Kavakli A, Ilhan N, et al., Efects of melatonin and octreotide on peridural fibrosis in an animal model of laminectomy. Turk Neurosurg 2010; 20: 50-56.
80. Trowbridge JM, Gallo RL,. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 2002; 12: 117R-125R.
81. Fang M, Goldstein EL, Turner AS, et al., Type I collagen D-spacing in fibril bundles of dermis, tendon, and bone: bridging between nano- and micro-level tissue hierarchy. ACS Nano 2012; 6: 9503-9514.
82. Simko F, Bednarova KR, Krajcirovicova K, et al., Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J Pineal Res 2014; 57: 177-184.
83. Simko F, Pechanova O, Repova Bednarova K, et al., Hypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin. Mediators Inflamm 2014; 2014: 703175.
84. Simko F, Pechanova O, Pelouch V, et al., Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril. J Hypertens 2010; 28 (Suppl 1): S13-S18.
85. Rosa DP, Bona S, Simonetto D, et al., Melatonin protects the liver and erythrocytes against oxidative stress in cirrhotic rats. Arq Gastroenterol 2010; 47: 72-78.
86. Paulis L, Pechanova O, Zicha J, et al., Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro- l -arginine-methyl ester hypertensive rats. J Hypertens Suppl 2009; 27: S11-S16.
87. Reiter RJ, Manchester LC, Fuentes-Broto L, et al., Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. J Hypertens 2010; 28 (Suppl 1): S7-S12.
88. Elbe H, Esrefoglu M, Vardi N, et al., Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats. Hum Exp Toxicol 2015; 34: 859-868.
89. Sapmaz E, Kale A, Akpolat N,. Melatonin use in unilateral total salpingectomy in rats. Clin Exp Obstet Gynecol 2012; 39: 186-190.
90. Ilbey YO, Ozbek E, Simsek A, et al., Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats. Fertil Steril 2009; 92: 1124-1132.
91. Esrefoglu M, Kurus M, Sahna E,. The beneficial effect of melatonin on chronic cyclosporin A nephrotoxicity in rats. J Int Med Res 2003; 31: 42-44.
92. Mizrak B, Parlakpinar H, Acet A, et al., Effects of pinealectomy and exogenous melatonin on rat hearts. Acta Histochem 2004; 106: 29-36.
93. Maarman G, Blackhurst D, Thienemann F, et al., Melatonin as a preventive and curative therapy against pulmonary hypertension. J Pineal Res 2015; 59: 343-353.
94. Shaker ME, Houssen ME, Abo-Hashem EM, et al., Comparison of vitamin E, L-carnitine and melatonin in ameliorating carbon tetrachloride and diabetes induced hepatic oxidative stress. J Physiol Biochem 2009; 65: 225-233.
95. Hong RT, Xu JM, Mei Q,. Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 2009; 15: 1452-1458.
96. San-Miguel B, Crespo I, Sanchez DI, et al., Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis. J Pineal Res 2015; 59: 151-162.
97. Han Y, Onori P, Meng F, et al., Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2014; 307: G894-G904.
98. Cho YA, Noh K, Jue SS, et al., Melatonin promotes hepatic differentiation of human dental pulp stem cells: clinical implications for the prevention of liver fibrosis. J Pineal Res 2015; 58: 127-135.
99. Yildirim Z, Kotuk M, Erdogan H, et al., Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats. J Pineal Res 2006; 40: 27-33.
100. Arslan SO, Zerin M, Vural H, et al., The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats. J Pineal Res 2002; 32: 21-25.
101. Stacchiotti A, Rezzani R, Angoscini P, et al., Small heat shock proteins expression in rat kidneys treated with cyclosporine A alone and combined with melatonin. Histochem J 2002; 34: 305-312.
102. Imamoglu M, Cay A, Cobanoglu U, et al., Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis. Urology 2006; 67: 1315-1319.
103. Attar R, Yildirim G, Kumbak B, et al., Efficacy of melatonin and hyaluronate/carboxymethylcellulose membrane in preventing adhesion reformation following adhesiolysis in a rat uterine model. J Obstet Gynaecol Res 2011; 37: 125-131.
104. Demirbag S, Cetinkursun S, Tasdemir U, et al., Comparison of hyaluronate/carboxymethylcellulose membrane and melatonin for prevention of adhesion formation in a rat model. Hum Reprod 2005; 20: 2021-2024.
105. Saeidi M, Sobhani R, Movahedi M, et al., Effect of melatonin in the prevention of postoperative pericardial adhesion formation. Interact Cardiovasc Thorac Surg 2009; 9: 26-28.
106. Ara C, Kirimlioglu H, Karabulut AB, et al., Protective effect of melatonin against oxidative stress on adhesion formation in the rat cecum and uterine horn model. Life Sci 2005; 77: 1341-1350.
107. Ozcelik B, Serin IS, Basbug M, et al., Effect of melatonin in the prevention of post-operative adhesion formation in a rat uterine horn adhesion model. Hum Reprod 2003; 18: 1703-1706.
108. Aritas Y, Akcan A, Erdogan AR, et al., Effects of melatonin and phospholipid on adhesion formation and correlation with vascular endothelial growth factor expression in rats. Ulus Travma Acil Cerrahi Derg 2009; 15: 416-422.
109. Koc O, Duran B, Topcuoglu A, et al., Intraperitoneal administration of single dose type I collagen or low dose melatonin to prevent intraperitoneal adhesion formation: a comparative study. Eur J Obstet Gynecol Reprod Biol 2009; 145: 209-213.
110. Ersoz N, Ozler M, Altinel O, et al., Melatonin prevents peritoneal adhesions in rats. J Gastroenterol Hepatol 2009; 24: 1763-1767.
111. Hatipoglu A, Turkyilmaz Z, Mert S,. The effects of melatonin on postoperative intraabdominal adhesion formation. Yonsei Med J 2007; 48: 659-664.
112. Aksakal O, Yilmaz B, Gungor T, et al., A randomised controlled trial on melatonin and rosiglitazone for prevention of adhesion formation in a rat uterine horn model. Arch Gynecol Obstet 2010; 282: 55-61.
113. Altungul AC, Kale A, Sapmaz E, et al., Examination of the effect of melatonin use in Pomeroy method of tubal ligation on ovarian histology in rats. Clin Exp Obstet Gynecol 2012; 39: 103-106.
114. Maria S, Witt-Enderby PA,. Melatonin effects on bone: potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures. J Pineal Res 2014; 56: 115-125.
115. Ayata A, Mollaoglu H, Yilmaz HR, et al., Oxidative stress-mediated skin damage in an experimental mobile phone model can be prevented by melatonin. J Dermatol 2004; 31: 878-883.
116. Drobnik J, Olczak S, Owczarek K, et al., Melatonin augments expression of the procollagen alpha1 (I) and alpha1 (III) genes in the infarcted heart scar of pinealectomized rats. Connect Tissue Res 2010; 51: 491-496.
117. Poeggeler B, Reiter RJ, Tan DX, et al., Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168.
118. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
119. Fischer TW, Kleszczynski K, Hardkop LH, et al., Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2′-deoxyguanosine) in ex vivo human skin. J Pineal Res 2013; 54: 303-312.
120. Gitto E, Pellegrino S, Gitto P, et al., Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009; 46: 128-139.
121. Drobnik J, Owczarek K, Piera L, et al., Melatonin-induced augmentation of collagen deposition in cultures of fibroblasts and myofibroblasts is blocked by luzindole-a melatonin membrane receptors inhibitor. Pharmacol Rep 2013; 65: 642-649.
122. Nakade O, Koyama H, Ariji H, et al., Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res 1999; 27: 106-110.
123. Sipahi M, Zengin K, Tanik S, et al., Effects of circadian rhythm disorders on wound healing and strength of bowel anastomosis in rats. Wounds 2014; 26: 317-322.